Systems analysis of human vaccine adjuvants

被引:39
作者
Harandi, Ali M. [1 ]
机构
[1] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden
关键词
Vaccine; Adjuvant; Vaccinology; Systems vaccinology; Omics; Transcriptomics; MOLECULAR SIGNATURES; SEASONAL INFLUENZA; TUBERCULOSIS; IMMUNOGENICITY; INFLAMMASOME; RESPONSES; BIOLOGY; ALUM; MF59;
D O I
10.1016/j.smim.2018.08.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The discovery and wide spread use of vaccines have saved millions of lives in the past few decades. Vaccine adjuvants represent an integral part of the modem vaccines. Despite numerous efforts, however, only a handful of vaccine adjuvants is currently available for human use. A comprehensive understanding of the mechanisms of action of adjuvants is pivotal to harness the potential of existing and new adjuvants in mounting desirable immune responses to counter human pathogens. Decomposing the host response to vaccines and its components at systems level has recently been made possible owing to the recent advancements in Omics technology and cutting edge immunological assays powered by systems biology approaches. This approach has begun to shed light on the molecular signatures of several human vaccines and adjuvants. This review is an attempt to provide an overview of the recent efforts in systems analysis of vaccine adjuvants that are currently in clinic.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 50 条
  • [41] New trends in vaccine research and development: Adjuvants, delivery systems and antigen formulations - Introduction
    Leclerc, C
    Ronco, J
    RESEARCH IN IMMUNOLOGY, 1998, 149 (01): : 9 - 9
  • [42] Vaccine adjuvants revisited
    Aguilar, J. C.
    Rodriguez, E. G.
    VACCINE, 2007, 25 (19) : 3752 - 3762
  • [43] Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses
    Pedersen, Gabriel Kristian
    Worzner, Katharina
    Andersen, Peter
    Christensen, Dennis
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [44] Stimulation Effects and Mechanisms of Different Adjuvants on a Norovirus P Particle-Based Active Amyloid-β Vaccine
    Dai, MingRui
    Feng, XueJian
    Mo, ZengShuo
    Sun, Yao
    Fu, Lu
    Zhang, Yong
    Wu, Jiaxin
    Yu, Bin
    Zhang, Haihong
    Yu, Xianghui
    Wu, Hui
    Kong, Wei
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (04) : 1717 - 1732
  • [45] The safety evaluation of adjuvants during vaccine development: The AS04 experience
    Garcon, Nathalie
    Segal, Lawrence
    Tavares, Fernanda
    Van Mechelen, Marcelle
    VACCINE, 2011, 29 (27) : 4453 - 4459
  • [46] Advances in vaccine adjuvants
    Singh, M
    O'Hagan, D
    NATURE BIOTECHNOLOGY, 1999, 17 (11) : 1075 - 1081
  • [47] Polymeric Nanoparticles as Immunomodulatory Vaccine Adjuvants for Atherosclerosis
    Ahuja, Sonali
    Petersen, Latrisha K.
    Maghe, Prabha V.
    Uhrich, Kathryn
    2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC), 2014,
  • [48] Rational Design and In Vivo Characterization of Vaccine Adjuvants
    Schmidt, Signe Tandrup
    Pedersen, Gabriel Kristian
    Christensen, Dennis
    ILAR JOURNAL, 2018, 59 (03) : 309 - 322
  • [49] Vaccine adjuvants: scientific challenges and strategic initiatives
    Harandi, Ali M.
    Davies, Gwyn
    Olesen, Ole F.
    EXPERT REVIEW OF VACCINES, 2009, 8 (03) : 293 - 298
  • [50] Current adjuvants and new perspectives in vaccine formulation
    Montomoli, Emanuele
    Piccirella, Simona
    Khadang, Baharak
    Mennitto, Elisa
    Camerini, Roberto
    De Rosa, Alfonso
    EXPERT REVIEW OF VACCINES, 2011, 10 (07) : 1053 - 1061